Onderneming Nextgen Biomed Ltd TEL AVIV STOCK EXCHANGE
Aandelen
NXGN
IL0010839301
Medische apparatuur, benodigdheden & distributie
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 48 | 20-11-22 | |
Dalia Mulakandov
DFI | Director of Finance/CFO | 39 | 17-01-23 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 08-08-00 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Grossman
BRD | Director/Board Member | 49 | 12-06-22 |
Yaacov Amidror
CHM | Chairman | 76 | 07-01-21 |
Alon Pinkas
BRD | Director/Board Member | 62 | 17-11-22 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 08-08-00 |
Tom Shabat
BRD | Director/Board Member | 35 | 06-12-22 |
Ilana Eldan
BRD | Director/Board Member | 43 | 18-12-22 |
Jacob Kaul
BRD | Director/Board Member | 74 | 17-11-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 8 082 701 | 7 441 086 ( 92,06 %) | 0 | 92,06 % |
Bedrijfsgegevens
Nextgen Biomed Ltd.
P. O. Box 4318
, Raanana
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,95% | 27,41 mld. | |
+21,48% | 2,36 mld. | |
+13,31% | 2,27 mld. | |
-48,88% | 2,2 mld. | |
-30,74% | 2,03 mld. | |
+21,11% | 1,84 mld. | |
-15,10% | 1,7 mld. | |
+6,58% | 1,34 mld. | |
+16,77% | 1,24 mld. |